NIH All About Grants Podcast – Discussing Not Discussed
Gene Carstea, Ph.D., Respiratory, Cardiac, and Circulatory Sciences Review Branch Chief, Center for Scientific Review, NIH
Your application was “not discussed.” What does this actually mean? What should you do next?
We are discussing “Not Discussed” in this NIH All About Grants podcast episode (Audio/Transcript). Dr. Gene Carstea, a Review Branch Chief at the Center for Scientific Review, will share insights on the NIH peer review process, how many applications are not discussed, reasons why, who to contact, appealing a not discussed decision, and much more.
“…If your application is not discussed, it do...
Source: NIH Extramural Nexus - March 29, 2023 Category: Research Authors: NIH Staff Tags: New Resources applications Peer review podcast Source Type: funding
Support Product Development and Entrepreneurial Training – Apply To Be a Research Evaluation and Commercialization Hub
Matt McMahon, Director, NIH Small business Education and Entrepreneurial Development (SEED)
We are excited to announce the release of a new funding opportunity aimed at strengthening the NIH Proof of Concept Network, an academic innovation ecosystem converting scientific discoveries into biomedical products at over 79 research institutions across 19 states. The funding will be used to stand up five new hubs that will increase research and development impact as well as stimulate regional innovation partnerships.
In less than 10 years, with only $74 million in NIH funding, the NIH Proof of Concept Network has led to the form...
Source: NIH Extramural Nexus - December 14, 2022 Category: Research Authors: NIH Staff Tags: blog Open Mike funding opportunities small business Source Type: funding
Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01)
Notice NOT-HL-22-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2022 Category: Research Source Type: funding
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-23-002 from the NIH Guide for Grants and Contracts. This funding opportunity annoucement (FOA) seeks applications for a Coordinating Center that will support the activities of a cooperative multi-siteAcute Respiratory Distress Syndrome (ARDS),Pneumonia, andSepsis Phenotyping Consortium (APS Consortium). The APS Consortium will seek to understand the heterogeneity and underlying mechanisms of critical illness syndromes and recovery, specifically in adults with ARDS, pneumonia, and/or sepsis, as well as the relationship and biological overlap among these syndromes. This will be accomplished thro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection
Notice NOT-HL-22-004 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 21, 2021 Category: Research Source Type: funding
Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-014 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications for the Clinical Coordinating Center (CCC) of Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). SIREN will enable conduct of high-quality, multi-site clinical trials to improve the outcomes for patients with neurologic, cardiac, respiratory, hematologic and trauma emergency events. SIREN will consist of one Clinical Coordinating Center (CCC), one Data Coordinating Center (DCC) and up to 10 clinical centers (Hubs). The CCC will facilitate ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2021 Category: Research Source Type: funding
Limited Competition: Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-013 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications for the Data Coordinating Center (DCC) for Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN). SIREN will enable conduct of high-quality, multi-site clinical trials to improve the outcomes for patients with neurologic, cardiac, respiratory, hematologic, and trauma emergency events. SIREN will consist of one Clinical Coordinating Center (CCC), one Data Coordinating Center (DCC) and up to 10 clinical centers (Hubs). The DCC will have respons...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2021 Category: Research Source Type: funding
Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network Clinical Center (Hub) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-22-015 from the NIH Guide for Grants and Contracts. (Reissue of RFA-NS-16-016) The purpose of this funding opportunity announcement (FOA) is to invite applications from new and existing sites to serve as Clinical Centers (Hubs) in the SIREN Network. SIREN conduct of several multi-center Phase III clinical trials, to improve the outcomes for patients with neurologic, cardiac, respiratory, hematologic, and traumatic conditions. SIREN is made up of one Clinical Coordinating Center (CCC), one Data Coordinating Center (DCC) and 11 clinical centers (Hubs). A Hub is usually an academic center or tert...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 19, 2021 Category: Research Source Type: funding
HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed)
Funding Opportunity RFA-HL-22-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) aims to stimulate the pre-clinical development of novel, pharmacotherapeutic candidates to selectively counteract opioid induced respiratory depression (OIRD), without blocking opioid analgesic benefits or inducing acute opioid withdrawal. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 30, 2021 Category: Research Source Type: funding
New FY 2020 RCDC Categories and Funding Data are Available (Including for Coronaviruses)
NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2020 actual spending data and estimates for FY 2021 and 2022.
“Coronaviruses” is a new category as part of this update. This category covers Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and all types of other coronaviruses. Footnote #28 on the RCDC Categorical Spending page indicates that the FY 2020 actuals include obligations from resources specified for NIH in FY 2020 COVID-19 related emergency supplemental appropriations and funding from FY 2020 annual appropriations. FY 2021 and FY 2...
Source: NIH Extramural Nexus - June 30, 2021 Category: Research Authors: NIH Staff Tags: New Resources coronavirus NIH budget RCDC Source Type: funding
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
Notice NOT-HL-20-814 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 15, 2020 Category: Research Source Type: funding
Notice of Early Expiration of NOT-AI-20-051 Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Notice NOT-AI-20-066 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 13, 2020 Category: Research Source Type: funding
Notice of Expiration of PAR-20-177 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)"
Notice NOT-AI-20-063 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2020 Category: Research Source Type: funding
Notice of Expiration of PAR-20-178 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)"
Notice NOT-AI-20-062 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2020 Category: Research Source Type: funding
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
Funding Opportunity RFA-DK-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancrea...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2020 Category: Research Source Type: funding
